Market revenue in 2023 | USD 12.7 million |
Market revenue in 2030 | USD 66.3 million |
Growth rate | 26.6% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 53.54% in 2023. Horizon Databook has segmented the Middle East & Africa artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of chronic ailments, such as respiratory disorders & heart diseases, and growing geriatric population are boosting the demand for improved healthcare facilities. The incidence of chronic disorders, such as obesity, cardiovascular diseases, and diabetes.
Is increasing rapidly, owing to various factors such as sedentary lifestyle, hypertension, poor eating habits, physical inactivity, & lack of sleep. In October, 2017, the government of UAE launched the UAE Strategy for AI, which uses an integrated digital system.
To provide quick & efficient solutions for the healthcare sector and minimizing the impact of chronic & dangerous diseases. In May 2018, The Department of Health, Abu Dhabi’s regulator in health sector introduced a policy to govern the use and implementation of AI in healthcare.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account